Home/Filings/4/0000905718-19-000777
4//SEC Filing

Bell John K 4

Accession 0000905718-19-000777

CIK 0001498382other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 4:22 PM ET

Size

5.1 KB

Accession

0000905718-19-000777

Insider Transaction Report

Form 4
Period: 2019-09-13
Bell John K
Director
Transactions
  • Purchase

    Common Stock

    2019-09-13$0.68/sh+35,000$23,74444,701 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6551 to $0.68 per share, inclusive. The reporting person undertakes to provide to DelMar Pharmaceuticals, Inc., any security holder of DelMar Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1
  • filerCIK 0001569585

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:22 PM ET
Size
5.1 KB